Oralair 300 IR
NDC 59617-0016, ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN, tablet, orally disintegrating, from Stallergenes.
- Product NDC
- 59617-0016
- Status
- Listed
- Labeler
- Stallergenes
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- SUBLINGUAL
- Product type
- STANDARDIZED ALLERGENIC
- Marketing category
- BLA
- Application
- BLA125471
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59617-0016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POA PRATENSIS POLLEN300 [IR]/1
- DACTYLIS GLOMERATA POLLEN300 [IR]/1
- ANTHOXANTHUM ODORATUM POLLEN300 [IR]/1
- LOLIUM PERENNE POLLEN300 [IR]/1
- PHLEUM PRATENSE POLLEN300 [IR]/1
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59617-0016-1 | 59617001601 | 1 BLISTER PACK in 1 BOX (59617-0016-1) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 59617-0016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59617-0016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59617-0016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.